Connect for Well-being

Launch of a "Humanoid Development Project" utilizing physical AI.

Announcement Regarding the Signing of a Naming Rights Sponsorship Agreement for Konoike Sports Park in Nara City

A survey was conducted in Obu City, Aichi Prefecture, regarding the current state of childhood myopia. While approximately 90% of parents intend to take preventative measures, only about 50% actually do so.

Rohto Eye Vision, Japan's only eye care product featuring a BTA formula specifically designed for children's eye inflammation, is now available.

New product launch: "V Rohto Dryguard Premium," an over-the-counter eye drop containing 1% high-molecular-weight chondroitin.

Regarding the issue of the old DRX brand website URL being redirected to a fraudulent site.

Initiatives to Ensure Safety in Cell Therapy

Notice of changes to packaging specifications due to environmental considerations

Publication of "Rohto Health White Paper 2025"

Please purchase from authorized Obagi retailers.

We are pleased to announce the 19th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

The 16th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 30th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided